No such alleviation was observed in the NPC-CM group where the counts of CD68+ and CD11b+ cells in the damaged area were significantly higher compared with the GPC-CM group (Figure 5a,b). This evidence concerns the gene CD68 and nasopharyngeal carcinoma.